Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00911508 · ClinicalTrials.gov registry record · NA
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 2,204
- Enrollment target
NCT00911508: Completed NA study, sponsored by Mayo Clinic.
NCT00911508 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 2,204 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00911508, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,204 participants
- Enrollment target
Study Summary
The (Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial) CABANA Trial has the overall goal of establishing the appropriate roles for medical and ablative intervention for atrial fibrillation (AF). The CABANA Trial is designed to test the hypothesis that the treatment strategy of left atrial catheter ablation for the purpose of eliminating atrial fibrillation (AF) will be superior to current state-of-the-art therapy with either rate control or rhythm control drugs for decreasing the incidence of the composite endpoint of total mortality, disabling stroke, serious bleeding, or cardiac arrest in patients with untreated or incompletely treated AF.
Interventions
- DEVICE Left atrial ablation
- DRUG Rate or Rhythm Control Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,204 participants |
| Start Date | 2009-11-13 |
| Est. Completion | 2017-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00911508
The ClinicalTrials.gov registry entry for NCT00911508 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Left atrial ablation is the first listed.
NCT00911508 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00911508 about?
NCT00911508 is a clinical study titled "Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial". The (Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial) CABANA Trial has the overall goal of establishing the appropriate roles for medical and ablative intervention for atrial fibrillation (AF). The CABANA Trial is designed to test the hypothesis that the treatment...
What is the current status of trial NCT00911508?
This trial is currently completed. It is a NA study. The enrollment target is 2,204 participants. The study started on 2009-11-13. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT00911508?
The interventions under investigation include: Left atrial ablation (DEVICE), Rate or Rhythm Control Therapy (DRUG).
Who is sponsoring clinical trial NCT00911508?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.